Trulieve Reports Strong Cash Flow, Successful Debt Refinancing, and Texas License Approval in Full Year 2025 Results

summarizeSummary

Trulieve Cannabis Corp. reported strong full year 2025 results, including record cash flow from operations and free cash flow, alongside successful debt refinancing and a new conditional license in Texas, despite flat revenue and a cautious Q1 2026 outlook.

check_boxKey Events

• Record Cash Flow Generation

  For the full year 2025, Trulieve generated record cash flow from operations of $273 million and free cash flow of $229 million, significantly strengthening its liquidity position.

• Successful Debt Repositioning

  The company redeemed $368 million of senior secured notes due in 2026 and closed $200 million in new senior secured notes due 2030 at a 10.5% interest rate, extending its debt maturity profile.

• Full Year 2025 Financial Performance

  Trulieve reported full year revenue of $1.2 billion, which was flat year-over-year, with an improved GAAP net loss of $116 million and adjusted EBITDA of $427 million, up 2% from 2024.

• Strategic Market Expansion in Texas

  The company was granted conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program, signaling future growth opportunities.

auto_awesomeAnalysis

This filing highlights Trulieve's significantly improved financial health, driven by robust cash flow generation and strategic debt management. The record free cash flow and successful refinancing of substantial near-term debt maturities are critical for a cannabis company, providing financial flexibility and extending its runway. While full-year revenue was flat and Q1 2026 guidance indicates a slight sequential decline, the company's ability to generate cash and strengthen its balance sheet is a strong positive signal. The conditional Texas license also positions Trulieve for future growth in a key market, underscoring its strategic expansion efforts.